Your browser doesn't support javascript.
loading
Current status of heart transplantation in Taiwan.
Wang, S-S; Wang, C-H; Chou, N-K; Chi, N-H; Huang, S-C; Yu, H-Y; Wu, I-H; Chen, Y-S; Ko, W-J; Tsao, C-I; Shun, C-T; Chu, S-H.
Afiliación
  • Wang SS; Department of Cardiovascular Surgery, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: wangp@ntu.edu.tw.
  • Wang CH; Department of Cardiovascular Surgery, National Taiwan University Hospital, Taipei, Taiwan.
  • Chou NK; Department of Cardiovascular Surgery, National Taiwan University Hospital, Taipei, Taiwan.
  • Chi NH; Department of Cardiovascular Surgery, National Taiwan University Hospital, Taipei, Taiwan.
  • Huang SC; Department of Cardiovascular Surgery, National Taiwan University Hospital, Taipei, Taiwan.
  • Yu HY; Department of Cardiovascular Surgery, National Taiwan University Hospital, Taipei, Taiwan.
  • Wu IH; Department of Cardiovascular Surgery, National Taiwan University Hospital, Taipei, Taiwan.
  • Chen YS; Department of Cardiovascular Surgery, National Taiwan University Hospital, Taipei, Taiwan.
  • Ko WJ; Department of Cardiovascular Surgery, National Taiwan University Hospital, Taipei, Taiwan.
  • Tsao CI; Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan.
  • Shun CT; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan.
  • Chu SH; Department of Cardiovascular Surgery, Far Eastern Memorial Hospital, Taipei, Taiwan.
Transplant Proc ; 46(3): 911-3, 2014 Apr.
Article en En | MEDLINE | ID: mdl-24767379
ABSTRACT

PURPOSE:

We reviewed the national results of heart transplantation in Taiwan.

METHODS:

From July 1987 to December 2012, 1354 patients underwent heart transplantation in 18 qualified heart centers in Taiwan. The transplantation volume and survival rate were reviewed.

RESULTS:

The median age of recipients was 49 years at surgery, with 37% in the International Society for Heart and Lung Transplantation (ISHLT)-1A, 30% in ISHLT-1B, and 32% in ISHLT-2. The allograft 1-, 3-, 5-, and 10-year survival rates were 78%, 68%, 61%, and 47%, respectively. Mostly difficult recipients were bridged by extracorporeal membrane oxygenation (ECMO) instead of ventricular assist device (VAD).

CONCLUSION:

The results of heart transplantation in Taiwan are comparable with ISHLT world results. In Taiwan, we use more ECMO than VAD for mechanical circulatory support to bridge critical recipients to heart transplantation.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Trasplante de Corazón Límite: Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Transplant Proc Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Trasplante de Corazón Límite: Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Transplant Proc Año: 2014 Tipo del documento: Article